Abstract
In the present study, a new lanthanide–Schiff base ligand complex with the chemical formula of [Pr2(dbm)4L2(CH3OH)2]·2CH3OH (1, H2L = N'-[(1E)-[5-(hydroxymethyl)furan-2-yl]methylidene]pyrazine-2-carbohydrazide, Hdbm = 1,3-diphenylpropane-1,3-dione) has been successfully prepared via reaction of Ln(dbm)3·2H2O with the H2L ligand under the solvothermal reaction condition. The biological activity of the new compound on the children nosocomial infection was determined and the mechanism was explored at the same time. Firstly, the content of the inflammatory cytokines released into the plasma during nosocomial infection was measured with enzyme linked immunosorbent assay (ELISA) detection kit. In addition to this, the relative expression of the survival genes in the Staphylococcus aureus was determined with real time reverse transcription-polymerase chain reaction (RT-PCR).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
